ASHENEWS reports that the National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert over the circulation of two counterfeit batches of Avastin 400mg/16ml, an anticancer medication manufactured by Roche Diagnostics GmbH, Germany.
Trending
- Expert links regular sex to longer life
- Dermatologists warn on harmful skin-bleaching practices
- Lagos generates 13,000 tonnes of waste daily
- Lagos leads as 117m Nigerians get NIN
- SpaceX launches private astronauts on first crewed polar orbit
- OpenAI raises $40bn at valuation of $300bn
- NiMet forecasts 3-day sunshine, cloudiness from Tuesday
- GAIA Africa calls for ban on unusable secondhand clothes in Africa
